Nowshin Papri
Dhaka, C, Bangladesh
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Anxiety and depression and their impact on functional recovery and quality of life in Guillain-Barré syndrome: a prospective cohort study in Bangladesh.
Journal: BMJ open
Published: August 06, 2026
Challenges in Diagnosis and Management of Crohn's Disease in Bangladesh With Long Term Follow-Up.
Journal: Clinical case reports
Published: November 22, 2025
Climatic and Geographic Variations of Antecedent Infections in Guillain-Barré Syndrome: A Long-Term Longitudinal Analysis From Bangladesh.
Journal: Journal of the peripheral nervous system : JPNS
Published: October 21, 2025
Measurement properties of the Inflammatory Rasch-built Overall Disability Scale (I-RODS) in patients with Guillain-Barré syndrome.
Journal: Journal of neurology
Published: October 19, 2025
Prognostic Nutritional Index as a Biomarker of Disease Severity and Long-Term Outcome in Guillain-Barré Syndrome.
Journal: Journal of the peripheral nervous system : JPNS
Published: September 09, 2025
Epidemiology and risk factors of Alzheimer's disease and related dementias in South and Southeast Asia: a systematic review and meta-analysis protocol.
Journal: BMJ open
Published: August 21, 2025
Patient-Reported Outcome Measures for Assessing Health-Related Quality of Life in Patients With Polyneuropathies, Focusing on Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy: A Systematic Review of Measurement Properties.
Journal: Journal of the peripheral nervous system : JPNS
Published: February 26, 2025
Pain determinants and quality of life in Guillain-Barre syndrome: a prospective cohort study.
Journal: BMJ neurology open
Published: September 30, 2024
Prediction of respiratory failure and prolonged mechanical ventilation in Guillain-Barré syndrome: A prospective cohort study in Bangladesh.
Journal: Journal of the peripheral nervous system : JPNS
Published: September 10, 2024
Results From a Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ANX005, a C1q Inhibitor, in Patients With Guillain-Barré Syndrome.
Journal: Journal of the peripheral nervous system : JPNS
Published: July 12, 2024
Management of Guillain-Barré syndrome in Bangladesh: Clinical practice, limitations and recommendations for low- and middle-income countries.
Journal: Journal of the peripheral nervous system : JPNS
Published: August 14, 2023
Last Updated: 09/26/2026